Customized Nutrition and Dietary Technologies
Microbiome-Based Liquid Biopsy and Diagnostics
Next-Generation Probiotics and Biotherapeutics
Our microbiome-based liquid biopsy product line offers non-invasive biotech kits and software for early disease detection.
AI agents identify liquid biopsy biomarkers through data mining in the ENBIOSIS Biobank. Our bioscience team then converts these biomarkers into advanced biotech products.
Our IBS treatment has a 78% success rate, with an IBS management service available for purchase, and our chronic constipation treatment boasts an 83% success rate.
ILIFEXTEND generic framework collects microbiome samples and lifestyle and health information from users through mail-in kits or on-site applications. These samples undergo next-generation sequencing, and the resulting data is stored in a biobank. AI algorithms then analyze this data to provide tailored solutions. This versatile pipeline can be adapted for various additional solutions that share the same operating system.